Építés alatt – nem éles oldal
Belépés

What researchers published on Neuroblasztóma

10 755 papers, newest first.

Showing 40 of 10 755

  • Daraxonrasib (RMC-6236) is an effective targeted therapy for RAS-mutant neuroblastoma.Molecular cancer therapeutics
  • Chylous Malignant Pleural Effusion in High-Risk Metastatic Neuroblastoma: A Rare Presentation and Management Challenge.Pediatric blood & cancer
  • Novel Fused Bicyclic Compounds as VRK1 Inhibitors for Treating Glioblastoma or Neuroblastoma.ACS medicinal chemistry letters
  • ÁttekintésGamma-delta T cells in neuroblastoma: Exploiting MHC-independent recognition to overcome the barriers of high-risk disease.Translational oncology
  • Tetrapeptide НАЕЕ Inhibits the Toxic Effect of Beta-Amyloid on NEURO2A Neuroblastoma Cells.Doklady biological sciences : proceedings of the Academy of Sciences of the USSR, Biological sciences sections
  • EsetismertetésEctopic olfactory neuroblastoma - complete response to chemotherapy following a late recurrence: A case report.Oncology letters
  • Detection of Antagonistic Interactions Between Cannabidiol and Temozolomide in Various Neuroblastoma and Glioblastoma Cell Lines in the MTT Assay by Means of Synergy Finder 3.0 Software and Log-Probit Isobolographic Analysis.International journal of molecular sciences
  • An interpretable machine learning model for predicting response to anti-GD2 combined with umbilical cord blood-derived natural killer cell immunotherapy in neuroblastoma.Frontiers in immunology
  • Intense Focal Renal 18F-MFBG Uptake Attributable to Radiation in a Pediatric Patient With Neuroblastoma.Clinical nuclear medicine
  • Bone marrow CD14+CD206+ M2-like monocyte-macrophages as a potential complementary biomarker for bone marrow MRD in high-risk neuroblastoma.Frontiers in oncology
  • A noninvasive risk stratification prediction model for neuroblastoma through integration of multidimensional clinical indicators.European journal of pediatrics
  • A Comprehensive Radiomics Model for Predicting Progression-Free Survival in High-Risk Neuroblastoma Based on CT Imaging.The British journal of radiology
  • Unconfirmed Linear 18F-MFBG Uptake Along the Spinal Canal in a Pediatric Patient With Neuroblastoma: A Potential Diagnostic Pitfall.Clinical nuclear medicine
  • Dual Malignancies in Costello Syndrome: Rhabdomyosarcoma and Neuroblastoma with a Literature Review.Klinische Padiatrie
  • Physiological Uterine Uptake of 18F-MFBG During Menstruation in a Pediatric Patient With Neuroblastoma.Clinical nuclear medicine
  • RAS inhibition limits oncogenic signaling and tumorigenesis in neuroblastoma regardless of RAS mutational status.Scientific reports
  • Analysis of Invasion Patterns in Occult Involvement Cases of Olfactory Neuroblastoma Using Anatomically Oriented Surgical Specimens.Cancer medicine
  • Plexiform neuroblastoma-like cutaneous schwannoma: report of a rare morphological variant.Pathologica
  • ÁttekintésRediscovering neuroblastoma pathology from the perspective of digital pathology and AI: Current challenges and future implications.Pathologica
  • Transcriptomic changes associated with the antiproliferative effects of indole-3-acetic acid in SH-SY5Y neuroblastoma cells: an exploratory study.Molecular biology reports
  • In Vivo Molecular Imaging of OGG1 Activity Using a Cyclic Cleavage-Amplified DNA Nanodevice.Analytical chemistry
  • EsetismertetésPrepubertal-type testicular teratoma with a neuroblastoma component in an infant: a case report.Frontiers in oncology
  • 18F-FDG PET/CT-based Metabolic-clinical prognostic model could refine risk stratification in high-risk neuroblastoma.BMC medical imaging
  • EsetismertetésMetastatic Neuroblastoma Presenting as Suspected Septic Arthritis: A Case Report.Cureus
  • Szisztematikus áttekintésThe role of microRNAs in neuroblastoma cell differentiation and their therapeutic potential: a systematic review.Frontiers in oncology
  • ÁttekintésRisk-adapted radiotherapy in pediatric neuroblastoma: current evidence, controversies, and future directions-a narrative review.Translational pediatrics
  • Integrated transcriptomic profiling identifies a clinically adverse iron-autophagy imbalance state in neuroblastoma.Translational pediatrics
  • 18F-mFBG PET Detects Neuroblastoma Recurrence Prior to 123I-mIBG SPECT.Journal of pediatric hematology/oncology
  • S100A9 Mediates Neuroblastoma-Associated Skeletal Muscle Atrophy via O-GlcNAcylation Repression and Activate Mitophagy Activation.Journal of cachexia, sarcopenia and muscle
  • Integrative Multi-Omics and Single-Cell Analyses Identify FKBP10 as a CAF-Associated Biomarker Linked to ECM Remodeling and Aggressiveness in Neuroblastoma.Oncology research
  • ÁttekintésHLA class I and II polymorphisms in pediatric neuroblastoma: mechanistic links to immune surveillance, tumor evolution, and clinical translation.Frontiers in genetics
  • IGF2BP1 knockdown associates with alternative splicing changes of transcription factor genes in neuroblastoma cells.Frontiers in oncology
  • ÁttekintésCellular senescence remodels the neuro-immune-tumour niche in neuroblastoma through SASP and core signalling pathways.Biochimica et biophysica acta. Reviews on cancer
  • Neuroblastoma of the Palate Masquerading as Melanotic Neuroectodermal Tumor of Infancy: A Rare Presentation With Diagnostic Dilemma.Pediatric blood & cancer
  • What's New in Olfactory Neuroblastoma: Updated Literature Review through the 2024 NASBS Annual Meeting.Journal of neurological surgery. Part B, Skull base
  • Spontaneous Regression of Relapsed CNS Neuroblastoma, FOXR2-Activated, Temporally Associated With Postoperative Pyoderma Gangrenosum.Pediatric blood & cancer
  • Heparan sulphate expression in high-risk neuroblastoma.Pediatric surgery international
  • Feasibility and Tolerability of Chemoimmunotherapy Given During Induction for Treatment of Patients With High-Risk Neuroblastoma: A Report From the Children's Oncology Group.Journal of clinical oncology : official journal of the American Society of Clinical Oncology
  • Epiphora as the only symptom of ectopic olfactory neuroblastoma.BMJ case reports
  • Chidamide combined with dinutuximab beta, irinotecan and temozolomide for relapsed or refractory neuroblastoma in children: protocol for a prospective, single-centre, open-label, single-arm, phase II study in China.BMJ open